The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis

Clinics and Research in Hepatology and Gastroenterology(2022)

引用 1|浏览11
暂无评分
摘要
•The risk of recurrence is as high as 60-70% in the patients who underwent surgical resection in bile duct cancer.•The 5-FU regimen is still widely used in digestive system tumors, but no meta-analysis had so far been published to provide the conclusion of evidence-based medicine•This study was performed based on the Cochrane Handbook for Systematic Reviews of Interventions and PRISMA guidelines
更多
查看译文
关键词
Biliary tract cancer,5-Fluorouracil,Adjuvant therapy,Surgery alone,Meta-analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要